{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:26:45Z","timestamp":1789450005216,"version":"build-2803163510"},"reference-count":57,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The hyper immunoglobulin M (IgM) syndrome (HIGM), characterized by recurrent infections, low serum IgG and IgA, normal or elevated IgM, and defective class switch recombination and somatic hypermutation, is a heterogenous disorder with at least 5 distinct molecular defects, including mutations of the genes coding for the CD40 ligand (CD40L) and IKK-gamma (NEMO) genes, both X-linked; and mutations of CD40, activation-induced cytidine deaminase (AICDA), and uracil-DNA glycosylase (UNG), associated with autosomal recessive HIGM syndromes. To investigate the molecular basis of HIGM, we determined the prevalence of mutations affecting these 5 genes in a cohort of 140 patients (130 males and 10 females). Those patients without a molecular diagnosis were subsequently evaluated for mutations of the following genes: inducible CO-stimulator molecule (ICOS), ICOS ligand (ICOSL), and if male, Bruton tyrosine kinase (Btk) and SLAM-associated protein (SAP\/SH2D1A). We found mutations of CD40L in 98 males; AICDA in 4 patients (3 males, 1 female); UNG in one adult male; and Btk in 3 boys. Of the remaining 25 males, one infant with hypohidrotic ectodermal dysplasia had a mutation of NEMO. None of the remaining 33 patients (24 males\/9 females) had mutations affecting CD40, ICOS, ICOSL, or SH2D1, and are best classified as common variable immune deficiency (CVID), although other genes, including some not yet identified, may be responsible.<\/jats:p>","DOI":"10.1182\/blood-2003-12-4420","type":"journal-article","created":{"date-parts":[[2004,9,10]],"date-time":"2004-09-10T00:24:45Z","timestamp":1094775885000},"page":"1881-1890","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":187,"title":["Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome"],"prefix":"10.1182","volume":"105","author":[{"given":"Wen-I","family":"Lee","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, School of Medicine, Seattle; the Department of Pediatrics, Chang Gung Children's Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan; the Department of Pediatrics and Medicine, University of Arizona, Tucson; and the Department of Medicine, University of California, Irvine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, School of Medicine, Seattle; the Department of Pediatrics, Chang Gung Children's Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan; the Department of Pediatrics and Medicine, University of Arizona, Tucson; and the Department of Medicine, University of California, Irvine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Schumacher","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, School of Medicine, Seattle; the Department of Pediatrics, Chang Gung Children's Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan; the Department of Pediatrics and Medicine, University of Arizona, Tucson; and the Department of Medicine, University of California, Irvine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leman","family":"Yel","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, School of Medicine, Seattle; the Department of Pediatrics, Chang Gung Children's Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan; the Department of Pediatrics and Medicine, University of Arizona, Tucson; and the Department of Medicine, University of California, Irvine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qili","family":"Zhu","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, School of Medicine, Seattle; the Department of Pediatrics, Chang Gung Children's Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan; the Department of Pediatrics and Medicine, University of Arizona, Tucson; and the Department of Medicine, University of California, Irvine."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans D.","family":"Ochs","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, University of Washington, School of Medicine, Seattle; the Department of Pediatrics, Chang Gung Children's Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan; the Department of Pediatrics and Medicine, University of Arizona, Tucson; and the Department of Medicine, University of California, Irvine."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223451407400_REF1","doi-asserted-by":"crossref","unstructured":"Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM Syndrome. Science. 1993;259: 990-993.","DOI":"10.1126\/science.7679801"},{"key":"2020021223451407400_REF2","doi-asserted-by":"crossref","unstructured":"Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72: 291-300.","DOI":"10.1016\/0092-8674(93)90668-G"},{"key":"2020021223451407400_","doi-asserted-by":"crossref","unstructured":"DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature. 1993;361: 541-543.","DOI":"10.1038\/361541a0"},{"key":"2020021223451407400_","doi-asserted-by":"crossref","unstructured":"Fuleihan R, Ramesh N, Loh R, et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci U S A. 1993;90: 2170-2173.","DOI":"10.1073\/pnas.90.6.2170"},{"key":"2020021223451407400_REF5","doi-asserted-by":"crossref","unstructured":"Korthauer U, Graf D, Mages HW, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993; 361: 539-541.","DOI":"10.1038\/361539a0"},{"key":"2020021223451407400_","doi-asserted-by":"crossref","unstructured":"Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131: 47-54.","DOI":"10.1016\/S0022-3476(97)70123-9"},{"key":"2020021223451407400_REF7","doi-asserted-by":"crossref","unstructured":"Winkelstein JA, Marino MC, Ochs HD, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine. 2003; 82: 373-384.","DOI":"10.1097\/01.md.0000100046.06009.b0"},{"key":"2020021223451407400_REF8","doi-asserted-by":"crossref","unstructured":"Ferrari S, Giliani S, Insalaco A, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. 2001;98: 12614-12619.","DOI":"10.1073\/pnas.221456898"},{"key":"2020021223451407400_REF9","doi-asserted-by":"crossref","unstructured":"Kutukculer N, Moratto D, Aydinok Y, et al. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr. 2003;142: 194-196.","DOI":"10.1067\/mpd.2003.41"},{"key":"2020021223451407400_REF10","doi-asserted-by":"crossref","unstructured":"Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIM2). Cell. 2000;102: 565-575.","DOI":"10.1016\/S0092-8674(00)00079-9"},{"key":"2020021223451407400_REF11","doi-asserted-by":"crossref","unstructured":"Minegishi Y, Lavoie A, Cunningham-Rundles C, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97: 203-210.","DOI":"10.1006\/clim.2000.4956"},{"key":"2020021223451407400_REF12","doi-asserted-by":"crossref","unstructured":"Jacobs H, Bross L. Towards an understanding of somatic hypermutation. Curr Opin Immunol. 2001;13: 208-218.","DOI":"10.1016\/S0952-7915(00)00206-5"},{"key":"2020021223451407400_REF13","doi-asserted-by":"crossref","unstructured":"Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol. 2002; 12: 1748-1755.","DOI":"10.1016\/S0960-9822(02)01215-0"},{"key":"2020021223451407400_REF14","doi-asserted-by":"crossref","unstructured":"Imai K, Slupphaung G, Lee WI, et al. Uracil-DNA glycosylase deficiency profoundly impairs immunoglobulin class switch recombination, leading to a hyper-IgM syndrome. Nat Immunol. 2003;10: 1023-1028.","DOI":"10.1038\/ni974"},{"key":"2020021223451407400_REF15","doi-asserted-by":"crossref","unstructured":"Yamaoka S, Courtois G, Bessia C, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93: 1231-1240.","DOI":"10.1016\/S0092-8674(00)81466-X"},{"key":"2020021223451407400_REF16","doi-asserted-by":"crossref","unstructured":"Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet. 2000;67: 1555-1562.","DOI":"10.1086\/316914"},{"key":"2020021223451407400_REF17","doi-asserted-by":"crossref","unstructured":"Doffinger R, Smahi A, Bessia C, et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet. 2001;27: 277-285.","DOI":"10.1038\/85837"},{"key":"2020021223451407400_REF18","doi-asserted-by":"crossref","unstructured":"Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2: 223-238.","DOI":"10.1038\/85277"},{"key":"2020021223451407400_REF19","doi-asserted-by":"crossref","unstructured":"Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 1999;397: 263-266.","DOI":"10.1038\/16717"},{"key":"2020021223451407400_REF20","doi-asserted-by":"crossref","unstructured":"Wang S, Zhu G, Chapoval AI, et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood. 2000;96: 2808-2813.","DOI":"10.1182\/blood.V96.8.2808"},{"key":"2020021223451407400_REF21","doi-asserted-by":"crossref","unstructured":"Ling V, Wu PW, Miyashiro JS, Marusic S, Finnerty HF, Collins M. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules. J Immunol. 2001;166: 7300-7308.","DOI":"10.4049\/jimmunol.166.12.7300"},{"key":"2020021223451407400_REF22","doi-asserted-by":"crossref","unstructured":"McAdam AJ, Greenwald RJ, Levin MA, et al. ICOS is critical for CD40-mediated antibody class switching. Nature. 2001;409: 102-105.","DOI":"10.1038\/35051107"},{"key":"2020021223451407400_REF23","doi-asserted-by":"crossref","unstructured":"Wong SC, Oh E, Ng CH, Lam KP. Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the co-stimulatory ligand B7-H2. Blood. 2003;102: 1381-1388.","DOI":"10.1182\/blood-2002-08-2416"},{"key":"2020021223451407400_REF24","doi-asserted-by":"crossref","unstructured":"Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adultonset common variable immunodeficiency. Nat Immunol. 2003;4: 261-268.","DOI":"10.1038\/ni902"},{"key":"2020021223451407400_REF25","doi-asserted-by":"crossref","unstructured":"Ochs HD, Smith CI. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine. 1996;75: 287-299.","DOI":"10.1097\/00005792-199611000-00001"},{"key":"2020021223451407400_REF26","doi-asserted-by":"crossref","unstructured":"Morra M, Silander O, Calpe S, et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood. 2001;98: 1321-1325.","DOI":"10.1182\/blood.V98.5.1321"},{"key":"2020021223451407400_REF27","doi-asserted-by":"crossref","unstructured":"Imai K, Catalan N, Plebani A, et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest. 2003;112: 136-142.","DOI":"10.1172\/JCI18161"},{"key":"2020021223451407400_REF28","unstructured":"Nutman TB. Generation and maintenance of T cell lines and clones. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EH, Strober W, eds. Current Protocols in Immunology. Vol 2. Somerest, NJ: Wiley; 1992:7.19: 1-7."},{"key":"2020021223451407400_REF29","doi-asserted-by":"crossref","unstructured":"Brunner C, Kreth HW, Ochs HD, Schuster V. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia. J Clin Immunol. 2002;22: 244-251.","DOI":"10.1023\/A:1016097010274"},{"key":"2020021223451407400_REF30","doi-asserted-by":"crossref","unstructured":"Nonoyama S, Penix LA, Edwards CP, et al. Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest. 1995;95: 66-75.","DOI":"10.1172\/JCI117677"},{"key":"2020021223451407400_REF31","doi-asserted-by":"crossref","unstructured":"Seyama K, Nonoyama S, Gangsaas I, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92: 2421-2434.","DOI":"10.1182\/blood.V92.7.2421"},{"key":"2020021223451407400_","unstructured":"Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405: 466-472."},{"key":"2020021223451407400_","doi-asserted-by":"crossref","unstructured":"Hashimoto S, Tsukada S, Matsushita M, et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood. 1996;88: 561-573.","DOI":"10.1182\/blood.V88.2.561.bloodjournal882561"},{"key":"2020021223451407400_REF34","doi-asserted-by":"crossref","unstructured":"Lee WI, Zhu Q, Gambineri E, Jin Y, Welcher A, Ochs HD. Inducible CO-stimulator molecule (ICOS), a candidate gene for defective isotype switching, is normal in patients with hyper IgM syndrome of unknown molecular diagnosis. J Allergy Clin Immunol. 2003;112: 958-964.","DOI":"10.1016\/S0091-6749(03)02021-9"},{"key":"2020021223451407400_REF35","doi-asserted-by":"crossref","unstructured":"Seyama K, Kobayashi R, Hasle H, et al. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis. 1998;178: 318-324.","DOI":"10.1086\/515633"},{"key":"2020021223451407400_REF36","doi-asserted-by":"crossref","unstructured":"Nonoyama S, Shimadzu M, Toru H, et al. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet. 1997;99: 624-627.","DOI":"10.1007\/s004390050417"},{"key":"2020021223451407400_REF37","doi-asserted-by":"crossref","unstructured":"Cunningham CK, Bonville CA, Ochs HD, et al. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. J Pediatr. 1999;134: 584-588.","DOI":"10.1016\/S0022-3476(99)70245-3"},{"key":"2020021223451407400_REF38","doi-asserted-by":"crossref","unstructured":"Noguchi E, Shibasaki M, Inudou M, et al. Association between a new polymorphism in the activation-induced cytidine deaminase gene and atopic asthma and the regulation of total serum IgE levels. J Allergy Clin Immunol. 2001;108: 382-386.","DOI":"10.1067\/mai.2001.117456"},{"key":"2020021223451407400_REF39","doi-asserted-by":"crossref","unstructured":"Mol CD, Arvai AS, Slupphaug G, et al. Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell. 1995;80: 869-878.","DOI":"10.1016\/0092-8674(95)90290-2"},{"key":"2020021223451407400_REF40","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274: 18470-18476.","DOI":"10.1074\/jbc.274.26.18470"},{"key":"2020021223451407400_REF41","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102: 553-563.","DOI":"10.1016\/S0092-8674(00)00078-7"},{"key":"2020021223451407400_REF42","doi-asserted-by":"crossref","unstructured":"Papavasiliou FN, Schatz DG. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature. 2000;408: 216-221.","DOI":"10.1038\/35041599"},{"key":"2020021223451407400_REF43","doi-asserted-by":"crossref","unstructured":"Petersen-Mahrt SK, Harris RS, Neuberger MS. AID mutates E coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 2002;418: 99-103.","DOI":"10.1038\/nature00862"},{"key":"2020021223451407400_REF44","doi-asserted-by":"crossref","unstructured":"Quartier P, Bustamante J, Sanal O, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol. 2004;110: 22-29.","DOI":"10.1016\/j.clim.2003.10.007"},{"key":"2020021223451407400_REF45","doi-asserted-by":"crossref","unstructured":"Ta VT, Nagaoka H, Catalan N, et al. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol. 2003:9: 843-848.","DOI":"10.1038\/ni964"},{"key":"2020021223451407400_REF46","doi-asserted-by":"crossref","unstructured":"Smahi A, Courtois G, Rabia SH, et al. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet. 2002;11: 2371-2375.","DOI":"10.1093\/hmg\/11.20.2371"},{"key":"2020021223451407400_REF47","doi-asserted-by":"crossref","unstructured":"Nonoyama S, Etzioni A, Toru H, et al. Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency. Eur J Immunol. 1998;28: 589-598.","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<589::AID-IMMU589>3.0.CO;2-J"},{"key":"2020021223451407400_","unstructured":"Ochs HD, Davis SD, Wedgwood, RJ. Immunologic responses to Bacteriophage \u03a6X 174 in immunodeficiency diseases. J Clin Immunol. 1971; 50: 2559-2568."},{"key":"2020021223451407400_REF49","doi-asserted-by":"crossref","unstructured":"Meyts I, Weemaes C, De Wolf-Peeters C, et al. Unusual and severe disease course in a child with ataxia-telangiectasia. Pediatr Allergy Immunol. 2003;14: 330-333.","DOI":"10.1034\/j.1399-3038.2003.00037.x"},{"key":"2020021223451407400_REF50","doi-asserted-by":"crossref","unstructured":"Casellas R, Nussenzweig A, Wuerffel R, et al. Ku80 is required for immunoglobulin isotype switching. EMBO J. 1998;17: 2404-2411.","DOI":"10.1093\/emboj\/17.8.2404"},{"key":"2020021223451407400_REF51","doi-asserted-by":"crossref","unstructured":"Bemark M, Sale JE, Kim HJ, Berek C, Cosgrove RA, Neuberger MS. Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med. 2000; 192: 1509-1514.","DOI":"10.1084\/jem.192.10.1509"},{"key":"2020021223451407400_REF52","doi-asserted-by":"crossref","unstructured":"Ehrenstein MR, Neuberger MS. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 1999;18: 3484-3490.","DOI":"10.1093\/emboj\/18.12.3484"},{"key":"2020021223451407400_","doi-asserted-by":"crossref","unstructured":"Wiesendanger M, Kneitz B, Edelmann W, Scharff MD. Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3\/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med. 2000;191: 579-584.","DOI":"10.1084\/jem.191.3.579"},{"key":"2020021223451407400_","doi-asserted-by":"crossref","unstructured":"Schrader CE, Vardo J, Stavnezer J. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J Exp Med. 2002;195: 367-373.","DOI":"10.1084\/jem.20011877"},{"key":"2020021223451407400_REF55","doi-asserted-by":"crossref","unstructured":"Schrader CE, Vardo J, Stavnezer J. Mlh1 can function in antibody class switch recombination independently of Msh2. J Exp Med. 2003;197: 1377-1383.","DOI":"10.1084\/jem.20022190"},{"key":"2020021223451407400_REF56","doi-asserted-by":"crossref","unstructured":"Bardwell PD, Woo CJ, Wei K, et al. Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice. Nat Immunol. 2004;5: 224-229.","DOI":"10.1038\/ni1031"},{"key":"2020021223451407400_REF57","doi-asserted-by":"crossref","unstructured":"Hollenbaugh D, Grosmaire LS, Kullas CD, et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992;12: 4313-4321.","DOI":"10.1002\/j.1460-2075.1992.tb05530.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/5\/1881\/1706849\/zh800505001881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/5\/1881\/1706849\/zh800505001881.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T03:56:05Z","timestamp":1585886165000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/5\/1881\/20287\/Molecular-analysis-of-a-large-cohort-of-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-12-4420","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}